Daniela Caronia

942 total citations
7 papers, 305 citations indexed

About

Daniela Caronia is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Daniela Caronia has authored 7 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Daniela Caronia's work include Cancer Treatment and Pharmacology (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Chemotherapy-related skin toxicity (2 papers). Daniela Caronia is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Chemotherapy-related skin toxicity (2 papers). Daniela Caronia collaborates with scholars based in Spain, Australia and Italy. Daniela Caronia's co-authors include Javier Benı́tez, Leticia T. Moreno, Guillermo Pita, Anna González‐Neira, Ana Patiño‐García, Marta Zalacaín, M. Rosario Alonso, Roger L. Milne, Raffaella Giavazzi and Angela Garofalo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Daniela Caronia

7 papers receiving 301 citations

Peers

Daniela Caronia

MB

ONCOL

PRM

CR

SS

P. Athanassiadou Greece

Olivia L. Snir United States

B Dębniak Poland

Yongick Ji South Korea

Alessandra Venanzi Italy

Elisa Varriale Italy

Loukia N. Lili United States

B Diouf United States

Ignacio I. Wistuba United States

P. Athanassiadou Greece

Daniela Caronia

159 ×1.0

MB

96 ×0.6

ONCOL

82 ×1.2

PRM

76 ×1.2

CR

5 ×0.2

SS

Citations per year, relative to Daniela Caronia Daniela Caronia (= 1×) peers P. Athanassiadou

Countries citing papers authored by Daniela Caronia

Since Specialization

Citations

This map shows the geographic impact of Daniela Caronia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Caronia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Caronia more than expected).

Fields of papers citing papers by Daniela Caronia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Caronia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Caronia. The network helps show where Daniela Caronia may publish in the future.

Co-authorship network of co-authors of Daniela Caronia

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Caronia. A scholar is included among the top collaborators of Daniela Caronia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Caronia. Daniela Caronia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pita, Guillermo, Miguel Martín, Rocío Núñez‐Torres, et al.. (2020). Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome. Clinical Pharmacology & Therapeutics. 109(2). 462–470. 6 indexed citations

2.

Martín, Miguel, Guillermo Pita, Daniela Caronia, et al.. (2018). Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel. Pharmacogenetics and Genomics. 28(11). 245–250. 4 indexed citations

3.

Caronia, Daniela, Ana Patiño‐García, Antonio Pérez‐Martínez, et al.. (2011). Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study. PLoS ONE. 6(10). e26091–e26091. 68 indexed citations

4.

Caronia, Daniela, Miguel Martín, Javier Sastre, et al.. (2011). A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome. Clinical Cancer Research. 17(7). 2006–2013. 67 indexed citations

5.

Martín, María P., Noelia Martínez-Jáñez, Manuel Ramos, et al.. (2011). Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009−05 study.. Journal of Clinical Oncology. 29(15_suppl). 1008–1008. 2 indexed citations

6.

Caronia, Daniela, Ana Patiño‐García, Roger L. Milne, et al.. (2009). Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. The Pharmacogenomics Journal. 9(5). 347–353. 99 indexed citations

7.

Belotti, Dorina, Angela Garofalo, Daniela Caronia, et al.. (2008). Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion. Molecular Cancer Research. 6(4). 525–534. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact